Friday, August 19, 2022
Home Tags Wuhan Zhong Yuan Rui De Biologics

Tag: Wuhan Zhong Yuan Rui De Biologics

CSL to buy majority stake in a leading Chinese plasma fractionator

Australian biotech firm CSL has agreed to acquire an 80% stake in China’s plasma-derived therapies manufacturer Wuhan Zhong Yuan Rui De Biologics (Ruide) in...
Advertisement

Featured Article

How to transform your operation into a smart factory: Building intelligent applications

The Australian manufacturing industry is fast entering the era of Industry 4.0. Harnessing the latest technology and transforming your operation into a smart factory is vital to building resilience, and optimising productivity and operational efficiency. And with the right help, it’s easier than you might think.